Farmaceutica REMEDIA S A Convening E.G.M.S. 2122 August 2024 - Marketscreener.com
| NR21 Stock | 35.20 3.20 10.00% |
About 55% of NR 21's investors are presently thinking to get in. The analysis of current outlook of investing in NR 21 SA suggests that some traders are interested regarding NR 21's prospects. The current market sentiment, together with NR 21's historical and current headlines, can help investors time the market. In addition, many technical investors use NR 21 SA stock news signals to limit their universe of possible portfolio assets.
NR21 |
Farmaceutica REMEDIA S A Convening E.G.M.S. 2122 August 2024 Marketscreener.com
Read at news.google.com
 |
NR 21 Fundamental Analysis
We analyze NR 21's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NR 21 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NR 21 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
NR 21 is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
NR 21 SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NR 21 stock to make a market-neutral strategy. Peer analysis of NR 21 could also be used in its relative valuation, which is a method of valuing NR 21 by comparing valuation metrics with similar companies.
Peers
NR 21 Related Equities
| SMCP | Smcp SAS | 2.65 | ||||
| PSAT | Passat Socit | 1.27 | ||||
| CAFO | Centrale DAchat | 1.28 | ||||
| ALDAR | Damartex | 2.99 |
Complementary Tools for NR21 Stock analysis
When running NR 21's price analysis, check to measure NR 21's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NR 21 is operating at the current time. Most of NR 21's value examination focuses on studying past and present price action to predict the probability of NR 21's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NR 21's price. Additionally, you may evaluate how the addition of NR 21 to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |